Lawrence Lamb

Lawrence Lamb

Company: IN8bio

Job title: Chief Scientific Officer


Maintaining Both Innate Killing & Specific Targeting of Heterogeneous Tumours with Chemotherapy-Resistant Chlorotoxin CAR-T Cells 10:45 am

Tumour heterogeneity can be addressed by upregulating broadly-expressed stress-induced surface antigens with chemotherapy and targeting these antigens with chemotherapy-resistant cells We will discuss the use of Chlorotoxin to improve delivery of CAR-T cells to the tumour site while maintaining their multiple tumour cytolytic functions. Supercharging optimisation and translation of allogeneic productsRead more

day: Day 2 - Track B - Morning

Chair’s Opening Remarks 8:05 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.